The association between the atherogenic index of plasma and all-cause mortality in patients undergoing peritoneal dialysis: a multicenter cohort study

被引:1
作者
Hu, Yaohua [1 ]
Yang, Liming [2 ]
Sun, Zhanshan [3 ]
Zhang, Xiaoxuan [4 ]
Zhu, Xueyan [5 ]
Li, Jian [1 ]
Li, Xinyang [1 ]
Yu, Mengyuan [1 ]
Cui, Wenpeng [1 ]
机构
[1] Second Hosp Jilin Univ, Dept Nephrol, 4026 Yatai St, Changchun 130041, Jilin, Peoples R China
[2] First Hosp Jilin Univ, Dept Nephrol, Eastern Div, Changchun 130041, Jilin, Peoples R China
[3] Xinganmeng Peoples Hosp, Dept Nephrol, Ulanhot 137400, Inner Mongolia, Peoples R China
[4] Jilin FAW Gen Hosp, Dept Nephrol, Changchun 130041, Jilin, Peoples R China
[5] Jilin Cent Hosp, Dept Nephrol, Jilin 132011, Jilin, Peoples R China
关键词
Atherogenic index of plasma; Peritoneal dialysis; All-cause mortality; DISEASE; RISK;
D O I
10.1186/s12944-025-02510-z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BackgroundThe Atherogenic Index of Plasma (AIP) has been reported as a strong predictor of all-cause mortality in the overall population. However, the lipid profile changes in individuals with end-stage kidney disease (ESKD) undergoing peritoneal dialysis (PD) may affect the prognostic utility of AIP for all-cause mortality. The connection between them remains unclear.MethodsThis study included patients receiving PD at five hospitals in China from January 1, 2013, to December 31, 2019, with follow-up until June 30, 2020. The primary exposure variable in this investigation was the logarithm of the triglycerides (TG)/high-density lipoprotein cholesterol (HDL-C) ratio, which was used to compute the AIP, and the outcome variable was all-cause mortality. A Cox proportional hazards regression model was employed to analyze the association between AIP and all-cause mortality. Moreover, stratified analyses were performed to investigate this association further. Kaplan-Meier curves were employed for survival analysis, assessing the prognostic implications of varying AIP levels. Nonlinear associations were examined using smooth curve fitting techniques.ResultsA total of 869 patients were included in this study, of whom 153 died during the follow-up period. An inverse association was observed between AIP and all-cause mortality risk in the highest tertile compared to the lowest tertile (HR: 0.56, 95% CI: 0.37-0.84) after correcting for potential confounding variables. Moreover, a nonlinear association was observed between the rates of all-cause mortality and AIP. A segmented Cox regression model identified an inflection point at an AIP value of 0.63 (P = 0.014 for the log-likelihood ratio test). More specifically, it was negatively associated with the all-cause mortality risk (HR: 0.42, 95% CI: 0.25-0.73, P = 0.002) when AIP was <= 0.63. On the other hand, AIP showed a positive association with the risk of all-cause mortality when it was more than 0.63 (HR: 8.94, 95% CI: 1.66-48.10, P = 0.011).ConclusionThe present study identified a non-linear association between AIP and all-cause mortality in patients receiving peritoneal dialysis.
引用
收藏
页数:9
相关论文
共 30 条
[1]  
BM. K, 2022, JAMA
[2]   Association of Serum Triglyceride to HDL Cholesterol Ratio with All-Cause and Cardiovascular Mortality in Incident Hemodialysis Patients [J].
Chang, Tae K. ;
Streja, Elani ;
Soohoo, Melissa ;
Kim, Tae Woo ;
Rhee, Connie M. ;
Kovesdy, Csaba P. ;
Kashyap, Moti L. ;
Vaziri, Nosratola D. ;
Kalantar-Zadeh, Kamyar ;
Moradi, Hamid .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 12 (04) :591-602
[3]  
duiyimuhan G, 2023, BMC Cardiovasc Disord, P23
[4]   Atherogenic index of plasma is associated with major adverse cardiovascular events in patients with type 2 diabetes mellitus [J].
Fu, Liyao ;
Zhou, Ying ;
Sun, Jiaxing ;
Zhu, Zhaowei ;
Xing, Zhenhua ;
Zhou, Shenghua ;
Wang, Yongjun ;
Tai, Shi .
CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
[5]   Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction [J].
Gaziano, JM ;
Hennekens, CH ;
ODonnell, CJ ;
Breslow, JL ;
Buring, JE .
CIRCULATION, 1997, 96 (08) :2520-2525
[6]   Selection of dialysis methods for end-stage kidney disease patients with diabetes [J].
Hu, Yao-Hua ;
Liu, Ya-Li ;
Meng, Ling-Fei ;
Zhang, Yi-Xian ;
Cui, Wen-Peng .
WORLD JOURNAL OF DIABETES, 2024, 15 (09)
[7]   Lessons from 30 years' data of Korean end-stage renal disease registry, 1985-2015 [J].
Jin, Dong-Chan ;
Yun, Sung Ro ;
Lee, Seoung Woo ;
Han, Sang Woong ;
Ki, Won ;
Park, Jongha ;
Kim, Yong Kyun .
KIDNEY RESEARCH AND CLINICAL PRACTICE, 2015, 34 (03) :132-139
[8]   Chronic kidney disease [J].
Kalantar-Zadeh, Kamyar ;
Jafar, Tazeen H. ;
Nitsch, Dorothea ;
Neuen, Brendon L. ;
Perkovic, Vlado .
LANCET, 2021, 398 (10302) :786-802
[9]  
Karakayal M., 2024, Kafkas J. Med. Sci, V14, P138, DOI [DOI 10.5505/KJMS.2024.86300, 10.5505/kjms.2024.86300]
[10]  
Kaysen GA, 2018, J LIPID RES, V59, P1519, DOI [10.1194/jlr.P084277, 10.1194/jlr.p084277]